-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Huntington's disease (HD) is an inherited disease that causes the death of brain cells.
Tominersen is an investigational antisense therapy designed to reduce the production of various forms of Huntingtin (HTT).
This decision is based on the results of a pre-planned review of data from the GENERATION HD1 study conducted by the Independent Data Monitoring Committee (iDMC).
Roche said in a statement that it will continue to track participants' safety and clinical results.
Levi Garraway, Roche’s Chief Medical Officer and Head of Global Product Development, said: “This is regrettable news.
Original source:
Original source:href="" target="_blank" rel="noopener">leave a message here